Publications by authors named "David Opalka"

Claim this Profile
M
Multiplexed serologic assay for nine anogenital human papillomavirus types.
David Opalka, Katie Matys, Paul Bojczuk, Tina Green, Richard Gesser

Clin Vaccine Immunol· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An oligosaccharide-based HIV-1 2G12 mimotope vaccine induces carbohydrate-specific antibodies that fail to neutralize HIV-1 virions.
Joseph G Joyce, Isaac J Krauss, Hong C Song, David W Opalka, Karen M Grimm

Proc Natl Acad Sci U S A· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HIV type 1 vaccines for worldwide use: predicting in-clade and cross-clade breadth of immune responses.
Adam C Finnefrock, Xiaomei Liu, David W Opalka, John W Shiver, Danilo R Casimiro

AIDS Res Hum Retroviruses· October 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of the HIV-1 gp41 specific immune response using a multiplexed antibody detection assay.
David Opalka, Antonello Pessi, Elisabetta Bianchi, Gennaro Ciliberto, William Schleif

J Immunol Methods· April 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Simultaneous quantitation of antibodies to neutralizing epitopes on virus-like particles for human papillomavirus types 6, 11, 16, and 18 by a multiplexed luminex assay.
David Opalka, Charles E Lachman, Stefani A MacMullen, Kathrin U Jansen, Judith F Smith

Clin Diagn Lab Immunol· January 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis